Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eye scanner works even when You're flat on your back

NCT ID NCT04661124

Knowledge-focused Sponsor: Heidelberg Engineering GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a special eye imaging device that can take pictures of the retina while a person lies down. Researchers compared images from the new device to those from a standard upright device in 88 adults with healthy eyes or retinal disease. The goal was to see if the new device produces images of similar quality and accuracy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could allow eye imaging for patients who cannot sit upright, such as those with disabilities or during surgery.
What could go wrong
This is a small, early-stage study focused on image quality, not treatment. The device may not prove better or safer than existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

88 people

The number who actually took part.

Started

Dec 2020

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with healthy eyes (AN), and adults with structural and vascular retinal abnormalities (AD)

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Adult Normal Eyes Population (AN) Inclusion Criteria for AN Population 1. Age ≥ 22 years 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions. 3. Physically able to be positioned in all required imaging positions (upright at chinrest and supine). 4. Able to fixate. 5. Best corrected visual acuity ≥ 20/40 in both eyes. Exclusion Criteria for AN Population 1. Eye with ocular media not sufficiently clear to obtain acceptable study-related imaging. 2. Subjects who cannot tolerate the imaging procedures. 3. Clinically significant ocular disease in either eye as determined by an Investigator. 4. Ocular surgical intervention (except for refractive laser surgery or cataract surgery) in either eye. Adult Posterior Segment Abnormality Eye Population (AD) Inclusion Criteria for AD Population 1. Age ≥ 22 years 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions. 3. Physically able to be positioned in all required imaging positions (upright at chinrest and supine). 4. Able to fixate. 5. Eye with a structural and vascular posterior segment abnormality due to ocular disease and/or trauma. Exclusion Criteria for AD Population 1. Eye with ocular media not sufficiently clear to obtain acceptable study-related imaging. 2. Subjects who cannot tolerate the imaging procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy eyes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy eyes Retinal disease

Contacts and locations

Locations

  • Duke Eye Center

    Durham, North Carolina, 27705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.